Edwards Lifesciences will announce its operating results for the quarter ended June 30, 2026, after the market closes on July 23. The company will host a conference call at 5:00 p.m. ET on the same day to discuss the financial performance.

Conference Call Details

Investors can participate in the conference call by dialing (877) 704-2848 or (201) 389-0893. The call will also be accessible live and archived on the "Investor Relations" section of the Edwards website at ir.edwards.com.

About Edwards Lifesciences

Edwards Lifesciences is a global structural heart innovation company focused on improving patient lives through breakthrough technologies and partnerships with clinicians. The company's products and solutions are designed to address unmet medical needs in the structural heart disease space.

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Edwards Lifesciences Corporation breached their fiduciary duties to shareholders. The investigation focuses on potential corporate misconduct and the impact on shareholder value. Shareholders may be able to seek corporate governance reforms, the return of funds to the company, or a court-approved financial incentive award.

The firm represents investors globally who have been affected by securities fraud and corporate misconduct. Halper Sadeh LLC has previously implemented corporate reforms and recovered millions of dollars for defrauded investors. Shareholder involvement is emphasized as a means to improve company policies, practices, and oversight mechanisms.

Potential Outcomes for Shareholders

If the investigation reveals breaches, shareholders may pursue several forms of relief:

• Corporate governance reforms
• Return of funds to the company
• Court-approved financial incentive awards
• Other relief and benefits

Contact Information

Shareholders currently holding Edwards stock, particularly long-term shareholders, are advised to contact the firm promptly. Daniel Sadeh and Zachary Halper are available at (212) 763-0060 or via email at sadeh@halpersadeh.com or zhalper@halpersadeh.com . The firm operates on a contingent fee basis, meaning shareholders are not responsible for out-of-pocket legal fees or expenses.